These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21916232)

  • 21. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
    Kristiansen IS; Kvien TK; Nord E
    Arthritis Rheum; 1999 Nov; 42(11):2293-302. PubMed ID: 10555023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis.
    Cheung R; Cheng TT; Dong Y; Lin HY; Lai K; Lau CS; Feng H; Parsons B
    Int J Rheum Dis; 2010 May; 13(2):151-7. PubMed ID: 20536600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 25. [Approaches to prediction of gastropathy development risk due to non-steroidal antiinflammatory drugs].
    Alekseeva AV; Murav'ev IuV
    Ter Arkh; 2000; 72(5):25-8. PubMed ID: 11109614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]].
    Krüger K
    MMW Fortschr Med; 2006 Nov; 148(48):12. PubMed ID: 17615761
    [No Abstract]   [Full Text] [Related]  

  • 27. [Topical therapy of arthritis with diclofenac is safe].
    Orthopade; 2014 Apr; 43(4):391. PubMed ID: 24843862
    [No Abstract]   [Full Text] [Related]  

  • 28. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reducing pain by oral enzyme therapy in rheumatic diseases].
    Klein G; Kullich W
    Wien Med Wochenschr; 1999; 149(21-22):577-80. PubMed ID: 10666820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Eisen GM; Goldstein JL; Hanna DB; Rublee DA
    Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K; Recker DP; Verburg KM
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
    Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diclofenac sodium.
    Small RE
    Clin Pharm; 1989 Aug; 8(8):545-58. PubMed ID: 2670397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of protracted administration of antiinflammatory and antalgic drugs on gastric mucosa (author's transl)].
    Pascal JP; Tournut R; Rumeau JL; Clanet J; Delpu J; Raillac JJ
    Gastroenterol Clin Biol; 1978 Jan; 2(1):15-22. PubMed ID: 306360
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety advantages of topical versus oral nonsteroidal antiinflammatory drugs.
    Altman RD
    J Rheumatol; 2011 Mar; 38(3):572; author reply 573. PubMed ID: 21362791
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis.
    Bakshi R
    Br J Clin Pract; 1996 Sep; 50(6):294-7. PubMed ID: 8983316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamin E in rheumatic disease therapy?].
    Rau R
    Z Rheumatol; 1998 Aug; 57(4):203-6. PubMed ID: 9782600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.